DPPA2: A Protein with Unique Structure and Multiple Functions

Target Name: DPPA2

NCBI ID: G151871

DPPA2

DPPA2: A Protein with Unique Structure and Multiple Functions

DPPA2 ( short for \"Deleted in a Promenade-like Aggregation\" 2) is a protein that is expressed in various tissues throughout the body. It is characterized by its unique structure, which consists of a long extracellular domain and a short intracellular tail. This structure has led toDPPA2's unique ability to interact with a wide range of molecules, including transcription factors, DNA-binding proteins, and metabolic enzymes.

DPPA2 has been shown to play a key role in a variety of biological processes, including cell signaling, DNA replication, and metabolism. It is also involved in the regulation of cellular processes that are critical for the development and maintenance of tissues.

One of the most promising aspects of DPPA2 is its potential as a drug target. Its unique structure and various functions make it an attractive target for drug developers who are looking for new and innovative treatments for a variety of diseases.

DPPA2 has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and metabolic disorders. It is also involved in the regulation of cellular processes that are critical for the development and maintenance of tissues, which makes it an important target for drugs that are aimed at preventing or treating these conditions.

One of the most promising aspects of DPPA2 is its ability to interact with a wide range of molecules. Its long extracellular domain, which is involved in various interactions with other proteins, DNA, and other molecules, makes it an attractive target for drugs that are designed to modulate these interactions.

DPPA2 is also involved in the regulation of cellular processes that are critical for the development and maintenance of tissues. This makes it an important target for drugs that are aimed at preventing or treating conditions that are characterized by the misregulation of cellular processes, such as cancer, neurodegenerative diseases, and metabolic disorders.

In addition to its potential as a drug target,DPPA2 is also a valuable biomarker for a variety of diseases. Its unique structure and various functions make it an attractive target for diagnostic tests, as well as for the development of new therapeutic approaches.

DPPA2's ability to interact with a wide range of molecules makes it an attractive target for drugs that are designed to modulate these interactions. Its long extracellular domain, which is involved in various interactions with other proteins, DNA, and other molecules, makes it an attractive target for drugs that are designed to modulate these interactions.

DPPA2 is also involved in the regulation of cellular processes that are critical for the development and maintenance of tissues. This makes it an important target for drugs that are aimed at preventing or treating conditions that are characterized by the misregulation of cellular processes, such as cancer, neurodegenerative diseases, and metabolic disorders.

In addition to its potential as a drug target and biomarker,DPPA2 is also an important player in the regulation of cellular processes that are critical for the development and maintenance of tissues. Its unique structure and various functions make it an attractive target for diagnostic tests, as well as for the development of new therapeutic approaches.

In conclusion,DPPA2 is a protein that is characterized by its unique structure and its various functions. Its ability to interact with a wide range of molecules makes it an attractive target for drug developers who are looking for new and innovative treatments for a variety of diseases. Its involvement in the regulation of cellular processes that are critical for the development and maintenance of tissues also makes it an important target for drugs aimed at preventing or treating conditions characterized by the misregulation of these processes.

DPPA2 is also a valuable biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and metabolic disorders. Its unique structure and various functions make it an attractive target for diagnostic tests, as well as for the development of new therapeutic approaches.

With its unique structure and various functions,DPPA2 is an attractive target for drug developers who are looking for new and innovative treatments for a variety of diseases. Its potential as a drug target and biomarker make it an important player in the development of new therapeutic approaches for a wide range of conditions.

Protein Name: Developmental Pluripotency Associated 2

Functions: Binds to target gene promoters, including NKX2-5 and SYCE1, but not GATA4, and may be involved in the maintenance of the active epigenetic status of these genes

The "DPPA2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DPPA2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets